Also, the high-tech healthcare that we are accustomed to in the US is generally only available to the upper classes in India or people who pay with foreign (>local) purchasing power. Some of the hospitals that provide high-tech care do some symbolic pro-bono care for the poor, financed in part by donations from Indians abroad and foreign medical tourists. (Source: my parents have donated to such hospitals, and I have some acquaintances who have gone to India to have cheaper-than-US specialty medical procedures performed).
To make the best comparison I can think of, spine surgery cost me 0.5-3 months of a local software engineer's salary. In the US the billing error might be 0.3-2 years of an American engineer's salary.
http://www.nytimes.com/2014/09/21/us/drive-by-doctoring-surp...
A friend who runs a biotech startup told me that most European companies developing medical devices and pharmaceuticals justify the high R&D costs and regulatory risks by targeting the high profit potential of the US market. In most non-US developed countries, they aren't allowed sell their product for as high a cost by law.